Aplex Bio and Hamilton Sign Comarketing Agreement for Hyperplex PCR Automation
Aplex Bio and Hamilton have entered a comarketing agreement for an automated liquid handling solution utilizing Aplex's Hyperplex PCR kits on Hamilton platforms. Hyperplex PCR technology enables detection of up to 100 targets in a single reaction, addressing limitations of traditional PCR and sequencing. This partnership aims to enhance scalability, reproducibility, and data integrity in laboratory automation.
Theia Market Signal Identification - AI Assisted
Aplex Bio and Hamilton have formed a comarketing agreement for an automated liquid handling solution that integrates Aplex's Hyperplex PCR kits with Hamilton's platforms. Hyperplex PCR employs proprietary nanoparticle probe technology to detect up to 100 targets per reaction and improves precision and cost-efficiency over traditional PCR methods.
The collaboration aims to enhance scalability, reproducibility, and data integrity of the hpPCR process. The integration allows for a streamlined workflow, enabling laboratories to access high-precision testing rapidly.
Comments